TCM Biotech International Corp. (TPE:4169)

TCM Biotech International Revenue

TCM Biotech International had revenue of 186.33M TWD in the quarter ending September 30, 2026, with 7.91% growth. This brings the company's total for the last twelve months to 715.30M, up 4.82% year-over-year. In the year 2025, TCM Biotech International had annual revenue of 685.49M with 2.84% growth. That makes TCM Biotech International the 33,344th largest company in the world by revenue and 1,724th in Taiwan.

• Revenue (ttm): 715.30M
• Revenue Growth: +4.82%
• P/S Ratio: 11.28
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 8.07B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical 627.77M 91.6%
• Functional Food 57.61M 8.4%
• Other Department 107.00K 0.0%

By Geography

Chart

• Taiwan 684.46M 99.8%
• Other 1.03M 0.2%

Fiscal year ended Dec 31, 2025 See the full TCM Biotech International breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	685.49M	18.96M	2.84%
Dec 31, 2024	666.53M	-303.09M	-31.26%
Dec 31, 2023	969.62M	167.20M	20.84%
Dec 31, 2022	802.42M	100.38M	14.30%
Dec 31, 2021	702.05M	-35.03M	-4.75%

Data Source: S&P Global Market Intelligence Last updated: Nov 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 14, 2026

Data Sources Report a data error